Understanding the Connection between Affective Symptoms and GLP-1
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used to treat type 2 diabetes and obesity, providing effective glycemic control, weight loss, and cardiovascular and renal benefits. However, research has emerged highlighting the potential neuropsychiatric and neuroprotective effects mediated via central GLP-1R. One of the key areas of interest is the connection between affective symptoms and GLP-1, particularly in individuals with depression, anxiety, or bipolar disorder.Exploring the Role of GLP-1 in Affective Symptoms
